Sernova Biotherapeutics SEOVF Stock
Sernova Biotherapeutics Price Chart
Sernova Biotherapeutics SEOVF Financial and Trading Overview
| Sernova Biotherapeutics stock price | 0.08 USD |
| Previous Close | 0.1 USD |
| Open | 0.1 USD |
| Bid | 0.08 USD x 12000000 |
| Ask | 0.08 USD x 6500000 |
| Day's Range | 0.08 - 0.1 USD |
| 52 Week Range | 0.07 - 0.14 USD |
| Volume | 68.16K USD |
| Avg. Volume | 68.69K USD |
| Market Cap | 30.21M USD |
| Beta (5Y Monthly) | 0.641 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SEOVF Valuation Measures
| Enterprise Value | 52.84M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.913 |
Trading Information
Sernova Biotherapeutics Stock Price History
| Beta (5Y Monthly) | 0.641 |
| 52-Week Change | -42.85% |
| S&P500 52-Week Change | 15.18% |
| 52 Week High | 0.14 USD |
| 52 Week Low | 0.07 USD |
| 50-Day Moving Average | 0.08 USD |
| 200-Day Moving Average | 0.1 USD |
SEOVF Share Statistics
| Avg. Volume (3 month) | 68.69K USD |
| Avg. Daily Volume (10-Days) | 220.25K USD |
| Shares Outstanding | 377.64M |
| Float | 326.77M |
| Short Ratio | N/A |
| % Held by Insiders | 10.51% |
| % Held by Institutions | 0.043% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2025 |
| Most Recent Quarter (mrq) | July 31, 2026 |
| Next Fiscal Year End | October 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -868.43% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -8935977 USD |
| Net Income Avi to Common (ttm) | -10288920 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 63.33K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 2.58M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.031 |
| Book Value Per Share (mrq) | -0.045448013 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4415609 USD |
| Levered Free Cash Flow (ttm) | -14833898 USD |
Profile of Sernova Biotherapeutics
| Country | United States |
| State | ON |
| City | Mississauga |
| Address | RPO Central Parkway |
| ZIP | L5A 4H2 |
| Phone | 917-751-5713 |
| Website | https://www.sernova.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.
Q&A For Sernova Biotherapeutics Stock
What is a current SEOVF stock price?
Sernova Biotherapeutics SEOVF stock price today per share is 0.08 USD.
How to purchase Sernova Biotherapeutics stock?
You can buy SEOVF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sernova Biotherapeutics?
The stock symbol or ticker of Sernova Biotherapeutics is SEOVF.
Which industry does the Sernova Biotherapeutics company belong to?
The Sernova Biotherapeutics industry is Biotechnology.
How many shares does Sernova Biotherapeutics have in circulation?
The max supply of Sernova Biotherapeutics shares is 377.64M.
What is Sernova Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Sernova Biotherapeutics PE Ratio is now.
What was Sernova Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Sernova Biotherapeutics EPS is -0.05 USD over the trailing 12 months.
Which sector does the Sernova Biotherapeutics company belong to?
The Sernova Biotherapeutics sector is Healthcare.
